Name: UMIN ID:
Unique ID issued by UMIN | UMIN000016991 |
---|---|
Receipt number | R000019718 |
Scientific Title | Phase II trial (Investigator-initiated clinical trial) of CH5424802 in patients with relapsed or refractory ALK-positive anaplastic large cell lymphoma |
Date of disclosure of the study information | 2015/04/01 |
Last modified on | 2020/11/20 16:21:41 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/03/31 17:43:00 | ||
2 | Update | 2015/08/05 09:06:50 | Organization Organization Category of Funding Organization Nationality of Funding Organization Nationality of Funding Organization |
|
3 | Update | 2016/01/26 10:21:14 | Organization Organization |
|
4 | Update | 2016/04/22 15:50:31 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
5 | Update | 2016/04/22 15:51:41 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
6 | Update | 2017/07/25 09:49:11 | UMIN ID1 |
|
7 | Update | 2017/07/25 09:50:12 | Recruitment status |
|
8 | Update | 2017/07/25 09:53:38 | Name of primary person or sponsor Organization |
|
9 | Update | 2017/10/02 09:13:52 | Last follow-up date |
|
10 | Update | 2018/05/02 09:08:12 | Date trial data considered complete |
|
11 | Update | 2018/06/27 14:02:23 | Institute Institute Organization Organization |
|
12 | Update | 2019/04/03 09:08:59 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
13 | Update | 2019/04/03 09:10:46 | Number of participants that the trial has enrolled Results Results Results date posted |
|
14 | Update | 2019/04/03 09:12:35 | Date of IRB |
|
15 | Update | 2020/07/20 10:43:26 | Recruitment status |
|
16 | Update | 2020/11/20 16:21:41 | Recruitment status |